PRARAM 9 HOSPITAL PUBLIC COMPANY LIMITEDSET: PR9🇹🇭 TH

Internal Control · 2024

Internal Control — Board Opinion

Summary of the Board's Opinion on Internal Control

The Board of Directors has reviewed and assessed the company's internal control system and is of the opinion that the system is adequate and appropriate for the size and nature of the company's business operations. It also complies with relevant laws, regulations, and adheres to the principles of Good Corporate Governance. Additionally, the company has implemented the internal control system effectively and has ensured that sufficient personnel are in place to carry out the system efficiently.

The internal control system encompasses 5 key components as per the COSO framework, with no significant observations from the auditor and internal audit units regarding shortcomings in internal controls.

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
COSO - Enterprise Risk Management Framework (ERM)

The Company recognizes the importance of internal control systems and ensures that is following the principles of Good Corporate Governance, including internal control guidelines and international frameworks. In order to achieve the corporate objectives, the Board of Directors therefore appointed three audit committee members who were able to perform their duties efficiently and independently. In addition, the appointed audit committee members are responsible for reviewing the internal control system and monitor various internal controls to ensure that it is sufficient and appropriate for business operations and efficient and effective operations and can prevent or mitigate risk or damage that may occur. The appointed audit committee members are as well responsible for providing financial reports that are accurate and reliable, ensuring compliance with laws, rules and regulations related to the Company’s business and relevant rules of the Stock Exchange of Thailand and the Securities and Exchange Commission.

The company has internal control system for both medical treatment and medical services which has been certified by the Joint Commission International (JCI), the United States, since 2010 till present, and the Clinical Care Program Certification (CCPC). The Company’s the internal control system can ensure compliance with the corporate governance policy while appropriate internal control system has been determined. The Internal Audit Department is independent from other departments in order to perform its duty in assessing the implementation of internal control system and reports the result to the Board of Directors on quarterly basis. The Company has outsourced the assessment activities to Accounting Revolution Co., Ltd. The Internal Audit Department also prepares the annual internal audit plan to be submitted to the Board of Directors for consideration and approval. The plan will be used for reviewing and supervising the implementation that is aligned with the plan and policy set forth by the Company. The internal control system has been continuously improved in terms of quality.

The Board of Directors has reviewed the sufficiency of the internal control system together with the report of internal control system auditing results, which the Audit Committee has reported to the Board of Directors on a quarterly basis. The report covered the details according to the COSO’s internal control principles (The Committee of Sponsoring Organization of the Treadway Commission) which consist of five components as follows:

1. Control Environment

The Company has established the organization structure for supervising and managing, and the consideration and approval authority to ensure that the internal control system effectively promotes and supports the achievement of objectives, and compliance with relevant laws, regulations, rules and standards under the principles of good corporate governance as appeared in the Company’s Code of Conduct. The Company communicates the requirements and penalties for the executives and employees to be aware of the importance and value of integrity and ethics as a corporate culture. The Code of Conduct covers various practices such as recognizing the roles and responsibilities of the Board of Directors as a leader that creates value for the business sustainably, setting objectives, the main goal of the business that aims for sustainability, effectively strengthening the Board of Directors, nomination and development of senior management and personnel management, promoting innovation and responsible business

operations, supervising to ensure that there are appropriate risk management and internal control system; as well

as maintaining financial credibility and disclosure the disclosure of information and support participation and communication with shareholders.

To achieve the goal of being a leading private hospital with medical excellence and comprehensive services covering treatment, prevention and control of diseases, rehabilitation and health promotion and to expand to new customers who value health promotion and wellness, the Company has formulated annual plans and strategic plans, including operational plan and budgets which serve as the operation framework. The Company has determined the Unit level Key Performance Indicators (KPI) with the main objective in aiming at developing service quality of the Company and evaluation based on responsible duties both in performance and core competency.

2. Risk Assessment

The company has realized the importance of systematic, effective and timely risk management. Therefore, the Company has appointed Risk Management Committee to report directly to the Audit Committee in order to perform its duties in determining guidelines, measures, action plan, risk management framework and policy that is consistent with the Company’s risk management, supervising, monitoring and assessing the risk management implementation according to the Company’s strategy and business direction; which covers internal and external risk management policies and scopes, strategic risks, operational risk, financial risk, compliance risk and macro risks, including disaster, pandemic, and political unrest. The Committee also manages and ensures that the patients are treated and served well according to the Joint Commission International (JCI) standard and the Company’s policy.

The Company also required the Total Quality Center (TQC) to consider and investigate on complaints related to service quality and ethics and report the result to the Risk Management Working Group. The risk management process has been developed based on the root causes analysis (RCA), Failure Mode Effect Analysis (FMEA) and Leading Key Risks Indicators. The Risk Management Working Committee reports directly to the Audit Committee on quarterly basis.

3.Control Activities

The Company formulated a policy and appropriate operating guidelines covering all process and put them in writing. The Company has clearly specified the scope of authority, preventive internal control process and monitoring process which support effective implementation across the organization. Responsibility to approve and manage assets is separated from accounting record and information technology to create check and balance of power and enable appropriate cross investigation.

The Company has regularly reviewed its internal control process at all levels in order to control risk management in support of the Company’s strategic plan and sustainable growth.

4.Information & Communication

The Company has in place the information system with appropriate security control, enabling the Company to retrieve quality information to support critical decision. Policy, regulations and guidelines are efficiently communicated to support the operation according to the internal control system. For example, executives communicated with employees through the knowledge sharing session with participation of representatives from all departments, meetings, Intranet, e-mail, announcement, and circulation of memorandum in communication channels within department and the organization, as well as appropriately and adequately reporting the Company’s information and news.

The Company assigned the Total Quality Center (TQC) to consider and follow up complaints on service quality and ethics and safely receive complaints and clues of fraudulent act and corruption from within and outside the Company.

The Company required adequate report of significant information to the Board of Directors and the Audit Committee on quarterly basis in order to monitor and benchmark the Company’s operating performance with goals, plans and strategic plan, risk management, observations of the auditors and recommendation for improvement, findings and recommendations of the internal auditors and preparation of the written meeting minutes of the Board of Directors and Subcommittees.

5. Monitoring Activities

The Company has in place a monitoring, internal control assessment, and compliance with Code of Conduct process. The Internal Audit Unit, which is independent from other departments, is responsible for reviewing the operations according to the internal control process and reports the results directly to the Audit Committee every quarter or immediately when significant defects are found. So far, no significant defects have been found.

Internal Control Deficiencies

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)000

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

No

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

The Company has set up the Internal Audit Unit and outsourced an internal auditor from Accounting Revolution Company Limited . The Audit Committee had considered the qualifications of Accounting Revolution Company Limited and was of the opinion that its qualifications were suitable and sufficient for performing its internal audit duties, assessing compliance with the internal control system set out by the Company and developing an annual internal audit plan for proposing to the Audit Committee for approval due to its independence and experience in performing internal audit functions.

In the year 2024, The auditors and the Internal Audit Department have found no significant observation related to the defect in internal control. The Audit Committee and the Board of Directors considered that the Company’s internal control system is sufficient and appropriate for the size and condition of the Company’s business operations, appropriately compliant to the related laws and regulations, good corporate governance principles, and internal control system. In addition, the Company has allocated sufficient manpower to effectively implement the internal control system.

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

Guidelines for the appointment, removal, and transfer of the head of the internal audit department.

1. Principles and Objectives: Rama 9 Hospital emphasizes the importance of independence and effectiveness in internal auditing to ensure that risk management, internal control, and corporate governance meet international standards. Therefore, the appointment, removal, and transfer of the head of the internal audit department must be in accordance with clear and transparent guidelines.

2. Appointment of the Head of Internal Audit

2.1 Qualifications of the Head of Internal Audit

- Possesses educational qualifications and professional certifications related to fields such as accounting, finance, auditing, or other relevant disciplines.

- Has at least 5 years of experience in internal auditing, risk management, or internal control.

- Demonstrates an understanding of laws, regulations, and standards relevant to the hospital business.

- Exhibits ethics, morality, and integrity.

- No history of fraud or conflicts of interest that could impact job performance.

2.2 Appointment process

- The Audit Committee is responsible for considering and proposing suitable candidates for the approval of the board of directors

- The board of directors has the authority to officially approve the appointment of the head of internal audit

- There should be a clear specification of the scope of responsibilities and the assessment criteria for performance.

3. Removal of the Internal Audit Supervisor

3.1 Reasons for Removal

- Inability to perform duties as assigned or performance below standard.

- Violation of ethical standards or behavior conflicting with professional ethics.

- Involvement in corruption or actions causing harm to the hospital.

- Conflict of interest that may affect the independence of internal audit work.

- Business reasons justifying removal, such as organizational restructuring.

3.2 Dismissal Process

- The Audit Committee is responsible for reviewing and considering the reasons for dismissal.

- If there are valid grounds, the Audit Committee will propose the matter to the Board of Directors for consideration.

- The Board of Directors has the final authority to decide and approve the dismissal.

- The reasons for dismissal must be communicated in writing to the Head of Internal Audit.

4. Relocation of Internal Audit Supervisors

4.1 Cases Eligible for Relocation

- To align with the organizational structure and hospital management strategies.

- To support career development for personnel in accordance with the human resource management plan.

- In cases of necessity due to business changes or organizational mergers.

4.2 Relocation Process

- Approval must be obtained from the Audit Committee before proceeding.

- The Audit Committee shall propose the matter to the Board of Directors for approval.

- A proper succession plan must be established to transfer responsibilities to the successor.

- Notify relevant departments of the relocation and prepare official announcement documentation.

5.Additional Provisions

- The appointment, dismissal, and transfer of the Head of Internal Audit must comply with the regulations of the Stock Exchange of Thailand and the standards of the internal audit profession.

- The Audit Committee has the authority to monitor the outcomes following the appointment, dismissal, or transfer to ensure that the process is conducted appropriately.

- The Head of Internal Audit who is dismissed or transferred must be treated fairly and provided with written notification of the reasons.

Related Party Transactions

Has Related Party Transactions

Yes

Counterparties & Transactions

Monetary Unit

1000000

Counterparties with Potential Conflicts

NamePerson / Juristic PersonType of BusinessNature of RelationshipAs of Date (YYYY-MM-DD)
SC Asset Corporation Public Company Limited Juristic PersonReal Estate & Construction / Real Estate Development

– Mr. Panthongthain Shinawatra / Ms. Pintongtha Shinawatra Kunnakornwong / and Ms. Pojman Damapong are the major shareholders with a total of approximately 60.39%.

– There are directors with the Company, namely Mr. Attapol Saritpantawat and Mrs. Vilasini Puttikaran .

– The Company's Executive Director is a director. Mr. Songsak Premsuk

2024-12-31T00:00
OAI Consultant & Management Co., Ltd. Juristic PersonHotel Business

- Mr. Panthongthain Shinawatra / Ms. Pintongtha Shinawatra Kunnakornwong / and Ms. Pojman Damapong are the major shareholders with a total of approximately 60.39%.

2024-12-31T00:00
SC Able Company LimitedJuristic PersonReal estate leasing and processing

- Mr. Panthongthain Shinawatra / Ms. Pinthongtha Shinawatra Kunnakornwong / Ms. Patongtarn Shinawatra and Ms. Pojman Damapong are indirect major shareholders totaling 60.39%.

- There are joint directors, Mr. Attapol Saritpantawat.

2024-12-31T00:00
Scope Co., Ltd.Juristic PersonEngaged in trading and service business, including real estate management services. Allocate land for condominiums.

- Mr. Panthongthain Shinawatra / Ms. Pintongtha Shinawatra Kunnakornwong / Ms. Patongtarn Shinawatra and Ms. Pojman Damapong are the major shareholders with a total of 54.35%.

- There are joint directors, Mr. Attapol Saritpantawat.

2024-12-31T00:00
V.Land Property Co., Ltd.Juristic PersonSale of residential, rental and real estate operations Real Estate Agents & Brokers

- Mr. Panthongthain Shinawatra / Ms. Pintongtha Shinawatra Kunnakornwong / Ms. Patongtarn Shinawatra and Ms. Pojman Damapong are the major shareholders with a total of 60.39%.

-There are joint directors, Mr. Attapol Saritpantawat.

2024-12-31T00:00
Solid Asset Company LimitedJuristic PersonHotel & Restaurant Business

There are directors. 2 people, namely Ms. Pinthongtha Shinawatra Kunnakornwong and Mr. Udomsak Ngoosiri, with 2 shareholders.

1. OAI Consultant & Management Co., Ltd. 99.99%

2. Mr. Udomsak Ngo Siri 0.01%

2024-12-31T00:00
OAI Management Co., Ltd.Juristic PersonRenting or leasing real estate

There are directors. 3 people, namely Ms. Pinthongtha Shinawatra Kunnakornwong. Mr. Udomsak Ngo Siri and Mrs. Kanchanapa Hongyan with 4 shareholders : 1. Ms. Pojman Damapong 10%

2. Ms. Pinthongtha Shinawatra Kunnakornwong 30%

3. Ms. Patongtarn Shinawatra 30%

4. Mr. Panthongthain Shinawatra 30%

2024-12-31T00:00
OAI Leasing Company LimitedJuristic PersonVehicle rental and rental services and real estate utility services.

There are directors. 3 people, namely Ms. Pinthongtha Shinawatra Kunnakornwong. Mr. Udomsak Ngo Siri and Mrs. Kanchanapa Honglai with 8 shareholders :

1. Dr. Thaksin Shinawatra 0.01%

2. Ms. Pojman Damapong 0.01%

3. Ms. Pinthongtha Shinawatra Kunnakornwong 2.5%

4. Miss Patongtarn Shinawatra 2.49%

5. P.T. Co., Ltd. Corporation 22.22%

6. Mrs. Kanchanapa Honglei 0.01%

7. OAI Management Co., Ltd. 50.55%

8. SC Office Plaza Co., Ltd . 22.22%

2024-12-31T00:00
B.B.D. Development Co., Ltd.Juristic PersonRental and business operations

There are directors. 3 people, namely Ms. Pinthongtha Shinawatra Kunnakornwong. Mr. Udomsak Ngo Siri and Mrs. Kanchanapa Honglei with 4 shareholders :

1. Mr. Panthongthain Shinawatra 30%

2. Ms. Pinthongtha Shinawatra Kunnakornwong 30%

3. Ms. Patongtarn Shinawatra 30%

4. Ms. Pojman Damapong 10%

2024-12-31T00:00
Bridge Group (Thailand) Co., Ltd.Juristic PersonTrading-consignment and provision of information on real estate services.

- Mr. Panthongthain Shinawatra / Ms. Pinthongtha Shinawatra Kunnakornwong / Ms. Patongtarn Shinawatra and Kunnu Pojman Damapong are the major shareholders with a total of approximately 54.35%.

- There are joint directors, Mr. Attapol Saritpantawat.

2024-12-31T00:00
Thaicom FoundationJuristic Person-

- Family, major shareholders of the Company are the founders.

- The joint directors are Mr. Bannapoj Damapong. Mr. Songsak Premsuk

2024-12-31T00:00
B.B.D. Property Co., Ltd. Juristic PersonReal Estate Business

The Chairman of the Board of Directors is the major shareholder, Mr. Bannapoj Damapong, who holds 99.99% of the direct shares.

2024-12-31T00:00
SC Expedition Co., Ltd. changed its name to SCX Corporation Co., Ltd.Juristic PersonIt operates a hotel business and covers other real estate businesses.

- Mr. Panthongthain Shinawatra / Ms. Pintongtha Shinawatra Kunnakornwong / Ms. Patongtarn Shinawatra and Kunnu Pojman Damapong are the major shareholders with a total of approximately 60.39%.

- There are joint directors, Mr. Attapol Saritpantawat.

2024-12-31T00:00
Voice TV Co., Ltd. Juristic PersonProduce programs for general broadcasts

- The Company's director, Mr. Bannapoj Damapong, is the major shareholder with a direct shareholding of 99.99%.

2024-12-31T00:00
Ms. Pojman Damapong ("Major Shareholder")Person

– 48.64% direct majority shareholder in the Company.

2024-12-31T00:00
Mr. Bannapot DamapongPerson

– Chairman of the Board of Directors

2024-12-31T00:00
Dr. Sathian PooprasertPerson

– Doctor who holds the position of Vice Chairman of the Board of Directors, Member of the Executive Committee, Chief Executive Officer and Authorized Director

2024-12-31T00:00
Dr. Prasert TrairatvorakulPerson

– Doctor who holds the position of Director of the Company, Member of the Executive Committee , Senior Deputy Managing Director and Authorized Director

2024-12-31T00:00
Dr. Viroon MavichakPerson

– Doctor who holds the position of Director of the Company, Member of the Executive Committee, Senior Deputy Managing Director and Authorized Director

2024-12-31T00:00
Dr. Mongkol TanjapatkulPerson

– Doctors who serve as consultants in advising the Company on projects

2024-12-31T00:00
Emeritus Professor. WG. CDR. Dr. Sirindhara Singhara Na AyutthayaPerson

– Independent Director, Member of the Audit Committee and Member of Nomination and Remuneration Committee

2024-12-31T00:00
Dr. Sathaporn PooprasertPerson

– Doctors who serve as consultants in advising the Company on projects

– and the younger brother of Dr. Sathian Pooprasert.

2024-12-31T00:00
Mrs. Chutima TrairatvorakulPerson

– Spouse of Dr. Prasert Trairatvorakul, who is a doctor who holds the position of Director of the Company, Member of the Executive Committee, Senior Deputy Managing Director and Authorized Director

2024-12-31T00:00
Dr. Thitiwat SriprasatPerson

– Spouse of the daughter of Dr. Prasert Triratwarakul, who is a doctor who holds the position of Director of the Company, Executive Director and Deputy Director of the Company.

2024-12-31T00:00
Dr. Pisit JiyasakPerson

– The daughter of Dr. Prasert Triratwarakul, who is a doctor who holds the position of Director of the Company, Executive Director and Deputy Director of the Company.

2024-12-31T00:00
Dr. Porn TrairatvorakulPerson

Daughter of Dr. Prasert Trairatvorakul, who is a doctor who holds the position of Director of the Company, Member of the Executive Committee Senior Deputy Managing Director and Authorized Director.

2024-12-31T00:00
Dr. Pakini PooprasertPerson

– The daughter of Dr. Sathian Pooprasert, who is a doctor who holds the position of Vice Chairman of the Board of Directors, Member of the Executive Committee and Chief Executive Officer and Authorized Director

2024-12-31T00:00
Mr. Attapol SariddipuntawatPerson

– Director and Chairman of the Executive Committee

2024-12-31T00:00
Mr. Kanit PatsamanPerson

– Independent Director, Chairman of the Audit Committee and Member of the Corporate Governance and Sustainable Business Development Committee

2024-12-31T00:00
Mr. Pisek JiyasakPerson

– Independent Director, Audit Committee, Nomination and Remuneration Committee, and Chairman of the Corporate Governance and Sustainable Business Development Committee of the Company.

2024-12-31T00:00
Dr. Thanai CharinsanPerson

– Independent Director Member of the Corporate Governance and Sustainable Business Development Committee of the Company and Executive Director of the Company

2024-12-31T00:00
Mrs. Vilasinee PuddhikarantPerson

– Director and Member of the Nomination and Remuneration Committee

2024-12-31T00:00
Dr. Somchai PinyopornphanitPerson

– Executive Director

2024-12-31T00:00
Mr. Songsak PremsukPerson

– Executive Director

2024-12-31T00:00
Ms. Kamaporn Tampipit Person

– Chief Financial Officer and Executive (The highest responsible person in Accounting and Finance)

2024-12-31T00:00
Ms. Paetongtarn ShinawatraPerson

- A daughter of Khunying Potjaman Damapong.

2024-12-31T00:00
Doctor GroupPerson

Doctors who hold the position of directors or executives are examined and treated at the hospital

2024-12-31T00:00

Transactions by Counterparty

Transactions
4.13 · Necessity: The Company provides medical services to SC employees. Assets and other organizations under the contract to provide medical treatment for such employees. The medical service rates are the same as those of general customers, and the payment period and discount rates are comparable to those of customers under medical service contracts and customers under the Company's general contracts. · Description: The Company provides medical services to the employees of SC Company. Asset Corporation Public Company Limited, as well as other organizations under the contract to provide medical treatment for employees, including: 1. OAI Consultant Tent & Management Co., Ltd. 2. SC Able Company Limited 3. Scope Co., Ltd. 4. V.Land Property Co., Ltd. 5. Solid Company Asset Co., Ltd. 6. OAI Management Co., Ltd. 7. OAI Leasing Company Limited 8. B.B.D. Development Co., Ltd. 9. Bridge Group (Thailand) Co., Ltd. 10. Thaicom Foundation 11. B.B.D. Property Co., Ltd. 12. SC Expedition Co., Ltd. The organization will pay the medical expenses to the company on behalf of the employees of each organization. · As of yesteryear: 3.75 · Nature of transaction: Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is a normal business transaction and is reasonable. The terms and conditions of the service are the same as those of customers under medical service contracts and customers under other contracting parties, with the same medical service rates as general customers, including discounts in accordance with the counterparty discount criteria set forth in the Company's pricing policy. In addition, the transaction is also beneficial to the company. In order to expand the customer base that comes to use the company's services. · As of year before yesteryear: 3.33 · 0.62 · Necessity: The company provides medical services to SC employees. Assets and other organizations under the contract to provide medical treatment for such employees. The medical service rates are the same as those of general customers, and the payment period and discount rates are comparable to those of customers under medical service contracts and customers under the Company's general contracts. · Description: The Company provides medical services to the employees of SC Company. Asset Corporation Public Company Limited, as well as other organizations under the contract to provide medical treatment for employees, including: 1. OAI Consultant Tent & Management Co., Ltd. 2. SC Able Company Limited 3. Scope Co., Ltd. 4. V.Land Property Co., Ltd. 5. Solid Company Asset Co., Ltd. 6. OAI Management Co., Ltd. 7. OAI Leasing Company Limited 8. B.B.D. Development Co., Ltd. 9. Bridge Group (Thailand) Co., Ltd. 10. Thaicom Foundation 11. B.B.D. Property Co., Ltd. 12. SC Expedition Co., Ltd. The organization will pay the medical expenses to the company on behalf of the employees of each organization. · As of yesteryear: 0.47 · Nature of transaction: Outstanding trade receivables at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is a normal business transaction and is reasonable. The terms and conditions of the service are the same as those of customers under medical service contracts and customers under other contracting parties, with the same medical service rates as general customers, including discounts in accordance with the counterparty discount criteria set forth in the Company's pricing policy. In addition, the transaction is also beneficial to the company. In order to expand the customer base that comes to use the company's services. · As of year before yesteryear: 0.39
0.69 · Necessity: As of 1 August 2024, the Company has entered into a space lease agreement with Solid Asset Co., Ltd. for a period of 1 years from 1 August 2024 to 31 July 2025 to operate the distribution business. Food & Drink · Description: The Company has entered into a lease agreement for space and services. On the 2nd floor of Building B to open Yang Chinese Cafe. The model of serving Hong Kong-style Chinese cuisine is to accommodate customers who come to use the service in Rama 9 Hospital. · As of yesteryear: 1.06 · Nature of transaction: Rental income · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and supports more customers who come to use Building B as an alternative for customers. There are a variety of restaurants and cuisines with reasonable rental conditions and rental rates. There is no transfer of interest between the Company and persons who may have a conflict with the rental rate of the space in the same building with other tenants. · As of year before yesteryear: 0.85 · 1.41 · Necessity: As of 1 August 2024, the Company has entered into a space lease agreement with Solid Asset Co., Ltd. for a period of 1 years from 1 August 2024 to 31 July 2025 to operate the distribution business. Food & Drink · Description: The Company has entered into a lease agreement for space and services. On the 2nd floor of Building B to open Yang Chinese Cafe. The model of serving Hong Kong-style Chinese cuisine is to accommodate customers who come to use the service in Rama 9 Hospital. · As of yesteryear: 1.58 · Nature of transaction: Service Fee Revenue · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and supports more customers who come to use Building B as an alternative for customers. There are a variety of restaurants and cuisines with reasonable rental conditions and rental rates. There is no transfer of interest between the Company and persons who may have a conflict with the rental rate of the space in the same building with other tenants. · As of year before yesteryear: 1.44 · 0.13 · Necessity: As of 1 August 2024, the Company has entered into a space lease agreement with Solid Asset Co., Ltd. for a period of 1 years from 1 August 2024 to 31 July 2025 to operate the distribution business. Food & Drink · Description: The Company has entered into a lease agreement for space and services. On the 2nd floor of Building B to open Yang Chinese Cafe. The model of serving Hong Kong-style Chinese cuisine is to accommodate customers who come to use the service in Rama 9 Hospital. · As of yesteryear: 0.13 · Nature of transaction: Rental income/service fee accrued at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and supports more customers who come to use Building B as an alternative for customers. There are a variety of restaurants and cuisines with reasonable rental conditions and rental rates. There is no transfer of interest between the Company and persons who may have a conflict with the rental rate of the space in the same building with other tenants. · As of year before yesteryear: 0.13 · 0.2 · Necessity: As of 1 August 2024, the Company has entered into a space lease agreement with Solid Asset Co., Ltd. for a period of 1 years from 1 August 2024 to 31 July 2025 to operate the distribution business. Food & Drink · Description: The Company has entered into a lease agreement for space and services. On the 2nd floor of Building B to open Yang Chinese Cafe. The model of serving Hong Kong-style Chinese cuisine is to accommodate customers who come to use the service in Rama 9 Hospital. · As of yesteryear: 0.2 · Nature of transaction: Other non-current assets · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and supports more customers who come to use Building B as an alternative for customers. There are a variety of restaurants and cuisines with reasonable rental conditions and rental rates. There is no transfer of interest between the Company and persons who may have a conflict with the rental rate of the space in the same building with other tenants. · As of year before yesteryear: 0.2 · 0.57 · Necessity: The company has entered into a contract to provide discounts on food and beverage coupons for health check-ups. · Description: Food coupons for health check-ups and doctor's meals · As of yesteryear: 0.49 · Nature of transaction: Expenditure, Food coupons for health check-ups and doctor's meals · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and there is no transfer of interest between the Company and persons who may have conflicts · As of year before yesteryear: 0.16 · 0.88 · Necessity: The company has entered into a contract to provide discounts on food and beverage coupons for health check-ups. · Description: Food coupons for health check-ups and doctor's meals · As of yesteryear: 0.16 · Nature of transaction: Accrued expenses at the end of the period, Food coupons for health check-ups and doctor's meals · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and there is no transfer of interest between the Company and persons who may have conflicts · As of year before yesteryear: 0.12 · 0.02 · Necessity: The company purchased food and snacks for the medical team for health check-ups and for the management meeting. · Description: Commodity trading and food costs · As of yesteryear: 0.01 · Nature of transaction: Expenditure, Commodity trading and food costs · Audit committee opinion: The Audit Committee has considered that the transaction is reasonable and there is no transfer of interest between the Company and persons who may have conflicts. · As of year before yesteryear: 0.0
0.03 · Necessity: The Company provides annual health check-ups to Voice TV's employees at a price, conditions, and services comparable to those provided by the Company to other corporate customers. · Description: The Company has provided annual health check-up services to Voice TV's employees, which Voice TV pays for the medical expenses to the Company on behalf of employees. · As of yesteryear: 0.15 · Nature of transaction: Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is a normal business transaction and is reasonable. The health check-up service rates are in accordance with the normal rates charged to customers of the contracting parties and/or other corporate customers. This may lead to the expansion of other medical services after health checkups. · As of year before yesteryear: 0.13 · 0.0 · Necessity: The Company provides annual health check-ups to Voice TV's employees at a price, conditions, and services comparable to those provided by the Company to other corporate customers. · Description: The Company has provided annual health check-up services to Voice TV's employees, which Voice TV pays for the medical expenses to the Company on behalf of employees. · As of yesteryear: 0.07 · Nature of transaction: Outstanding trade receivables at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is a normal business transaction and is reasonable. The health check-up service rates are in accordance with the normal rates charged to customers of the contracting parties and/or other corporate customers. This may lead to the expansion of other medical services after health checkups. · As of year before yesteryear: 0.09
4.0 · Necessity: Therefore, the Company and its major shareholders have agreed to enter into a medical service contract as of 15 December 2017 and cancel the previous medical service contract with a discount rate of 15% (which is a discount rate with exemption conditions, which include doctor's fee, dental fee, physical therapy fee, doctor's reading fee, medical technical examination and pathology (special), beauty fee, and lump-sum service fee) and payment terms of 30 days from the date of billing, in accordance with the discount criteria under the medical service contract set forth in the Company's price policy. At the time of the preparation of a new medical service contract of the major shareholder in December 2017, the Company prepared an additional medical service contract with the new counterparty who is a relative of the major shareholder. It was under the original contract of the major shareholder. For the accounting period, the end of the 31 December 2018 and for the year ended 31 December 2017 , the said contract includes the service recipients referred by the parties. The total value of medical expenses was 7.5 million baht and 7.6 million baht, respectively. The value of medical expense discounts amounted to 1.5 million baht and 1.0 million baht, respectively, and the net value of medical expense income amounted to 6.0 million baht and 6.6 million baht, respectively, or an average discount rate of about 20 percent and 20 percent, respectively. The Company terminated the contract on 16 July 2018. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and the major shareholders (the contract covers the major shareholders and the persons under the contract), including the service recipients recommended by the major shareholders. Transactions in which the major shareholders pay medical expenses to the Company on behalf of the recipients of such services. · As of yesteryear: 1.98 · Nature of transaction: Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the company's services. However, The list of medical services in the period before the payment terms and discount rates were updated is a historical item. However, the price, conditions, and services, as well as discounts, under the current version of the Medical Service Contract are within the normal criteria of customers under the Medical Service Contract and customers according to the Company's pricing policy. · As of year before yesteryear: 5.43 · 0.42 · Necessity: Therefore, the Company and its major shareholders have agreed to enter into a medical service contract as of 15 December 2017 and cancel the previous medical service contract with a discount rate of 15% (which is a discount rate with exemption conditions, which include doctor's fee, dental fee, physical therapy fee, doctor's reading fee, medical technical examination and pathology (special), beauty fee, and lump-sum service fee) and payment terms of 30 days from the date of billing, in accordance with the discount criteria under the medical service contract set forth in the Company's price policy. At the time of the preparation of a new medical service contract of the major shareholder in December 2017, the Company prepared an additional medical service contract with the new counterparty who is a relative of the major shareholder. It was under the original contract of the major shareholder. For the accounting period, the end of the 31 December 2018 and for the year ended 31 December 2017 , the said contract includes the service recipients referred by the parties. The total value of medical expenses was 7.5 million baht and 7.6 million baht, respectively. The value of medical expense discounts amounted to 1.5 million baht and 1.0 million baht, respectively, and the net value of medical expense income amounted to 6.0 million baht and 6.6 million baht, respectively, or an average discount rate of about 20 percent and 20 percent, respectively. The Company terminated the contract on 16 July 2018. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and the major shareholders (the contract covers the major shareholders and the persons under the contract), including the service recipients recommended by the major shareholders. Transactions in which the major shareholders pay medical expenses to the Company on behalf of the recipients of such services. · As of yesteryear: 0.22 · Nature of transaction: Medical service discounts · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the company's services. However, The list of medical services in the period before the payment terms and discount rates were updated is a historical item. However, the price, conditions, and services, as well as discounts, under the current version of the Medical Service Contract are within the normal criteria of customers under the Medical Service Contract and customers according to the Company's pricing policy. · As of year before yesteryear: 0.61 · 3.58 · Necessity: Therefore, the Company and its major shareholders have agreed to enter into a medical service contract as of 15 December 2017 and cancel the previous medical service contract with a discount rate of 15% (which is a discount rate with exemption conditions, which include doctor's fee, dental fee, physical therapy fee, doctor's reading fee, medical technical examination and pathology (special), beauty fee, and lump-sum service fee) and payment terms of 30 days from the date of billing, in accordance with the discount criteria under the medical service contract set forth in the Company's price policy. At the time of the preparation of a new medical service contract of the major shareholder in December 2017, the Company prepared an additional medical service contract with the new counterparty who is a relative of the major shareholder. It was under the original contract of the major shareholder. For the accounting period, the end of the 31 December 2018 and for the year ended 31 December 2017 , the said contract includes the service recipients referred by the parties. The total value of medical expenses was 7.5 million baht and 7.6 million baht, respectively. The value of medical expense discounts amounted to 1.5 million baht and 1.0 million baht, respectively, and the net value of medical expense income amounted to 6.0 million baht and 6.6 million baht, respectively, or an average discount rate of about 20 percent and 20 percent, respectively. The Company terminated the contract on 16 July 2018. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and the major shareholders (the contract covers the major shareholders and the persons under the contract), including the service recipients recommended by the major shareholders. Transactions in which the major shareholders pay medical expenses to the Company on behalf of the recipients of such services. · As of yesteryear: 1.75 · Nature of transaction: Net Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the company's services. However, The list of medical services in the period before the payment terms and discount rates were updated is a historical item. However, the price, conditions, and services, as well as discounts, under the current version of the Medical Service Contract are within the normal criteria of customers under the Medical Service Contract and customers according to the Company's pricing policy. · As of year before yesteryear: 4.82 · 0.53 · Necessity: Therefore, the Company and its major shareholders have agreed to enter into a medical service contract as of 15 December 2017 and cancel the previous medical service contract with a discount rate of 15% (which is a discount rate with exemption conditions, which include doctor's fee, dental fee, physical therapy fee, doctor's reading fee, medical technical examination and pathology (special), beauty fee, and lump-sum service fee) and payment terms of 30 days from the date of billing, in accordance with the discount criteria under the medical service contract set forth in the Company's price policy. At the time of the preparation of a new medical service contract of the major shareholder in December 2017, the Company prepared an additional medical service contract with the new counterparty who is a relative of the major shareholder. It was under the original contract of the major shareholder. For the accounting period, the end of the 31 December 2018 and for the year ended 31 December 2017 , the said contract includes the service recipients referred by the parties. The total value of medical expenses was 7.5 million baht and 7.6 million baht, respectively. The value of medical expense discounts amounted to 1.5 million baht and 1.0 million baht, respectively, and the net value of medical expense income amounted to 6.0 million baht and 6.6 million baht, respectively, or an average discount rate of about 20 percent and 20 percent, respectively. The Company terminated the contract on 16 July 2018. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and the major shareholders (the contract covers the major shareholders and the persons under the contract), including the service recipients recommended by the major shareholders. Transactions in which the major shareholders pay medical expenses to the Company on behalf of the recipients of such services. · As of yesteryear: 0.25 · Nature of transaction: Outstanding trade receivables at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the company's services. However, The list of medical services in the period before the payment terms and discount rates were updated is a historical item. However, the price, conditions, and services, as well as discounts, under the current version of the Medical Service Contract are within the normal criteria of customers under the Medical Service Contract and customers according to the Company's pricing policy. · As of year before yesteryear: 0.29 · 0.0 · Necessity: The Company entered into a contract to purchase and sell land deed No. 6224, Land No. 314, Survey Page 2014, next to Thiam Ruam Mitr Road, Huai Khwang Sub-district, Huai Khwang District, Bangkok Province with the major shareholders for the purpose of constructing a new nursing dormitory building. To support the number of nurses of the company that will increase in the future. It was found that the land deed No. 6224, land number 314, survey page 2014 is suitable for the construction of a new nursing dormitory because this land is located in the same area as the company's existing nursing dormitory. It is not far from the company's location. This creates a good quality of life and work, benefits themselves and supports the company's growth. · Description: The Company has entered into a contract to buy and sell land with the major shareholder on March 9, 2023 to purchase the plot of land. Land Deed No. 6224, Land No. 314, Survey Page 2014, size 1 rai, 13 square wah (413 square wah) at a price of 100,000,000 baht, in which the company has deposited a deposit of 15,000,000 baht for the land on the date of purchase and sale and will pay the remaining land fee on the date of transfer of ownership of 85,000,000 baht by payment bill dated April 20, 2023. · As of yesteryear: 100.0 · Nature of transaction: Purchase of fixed assets · Audit committee opinion: The Audit Committee has considered that the transaction is necessary and beneficial to the Company, and the price and conditions of the purchase and sale agreement are appropriate and reasonable. The land price is lower than the appraised price by the appraisal of the company at Preeksa First Star Co., Ltd., Asset Asia Corporation Co., Ltd. and Rich Apprentice Co., Ltd., which is an asset valuation company approved by the Securities and Exchange Commission according to the Announcement No. SCOR 24/2012. The land is in a good location and will benefit both the company and the shareholders as a whole. · As of year before yesteryear: 0.0
0.45 · Necessity: As of 1 April 2018, the Company has entered into a medical service contract with Mr. Bannapot Damapong with the characteristics of conditions and discounts for groups of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions including doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic and pathology (special) fees, beauty salon fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set forth in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.44 · Nature of transaction: Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.37 · 0.05 · Necessity: As of 1 April 2018, the Company has entered into a medical service contract with Mr. Bannapot Damapong with the characteristics of conditions and discounts for groups of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions including doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic and pathology (special) fees, beauty salon fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set forth in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.05 · Nature of transaction: Medical service discounts · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.04 · 0.41 · Necessity: As of 1 April 2018, the Company has entered into a medical service contract with Mr. Bannapot Damapong with the characteristics of conditions and discounts for groups of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions including doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic and pathology (special) fees, beauty salon fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set forth in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.39 · Nature of transaction: Net Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.33 · 0.01 · Necessity: As of 1 April 2018, the Company has entered into a medical service contract with Mr. Bannapot Damapong with the characteristics of conditions and discounts for groups of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions including doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic and pathology (special) fees, beauty salon fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set forth in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.05 · Nature of transaction: Outstanding trade receivables at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.01
1.21 · Necessity: As of 22 May 2020 , the Company has entered into a medical service contract with Ms. Patongtarn Shinawatra with the characteristics of conditions and discounts for the group of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions such as doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic examination and pathology (special), beauty fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set out in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 1.19 · Nature of transaction: Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.69 · 0.09 · Necessity: As of 22 May 2020 , the Company has entered into a medical service contract with Ms. Patongtarn Shinawatra with the characteristics of conditions and discounts for the group of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions such as doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic examination and pathology (special), beauty fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set out in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.18 · Nature of transaction: Medical service discounts · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.06 · 1.12 · Necessity: As of 22 May 2020 , the Company has entered into a medical service contract with Ms. Patongtarn Shinawatra with the characteristics of conditions and discounts for the group of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions such as doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic examination and pathology (special), beauty fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set out in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 1.01 · Nature of transaction: Net Medical service income · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.63 · 0.09 · Necessity: As of 22 May 2020 , the Company has entered into a medical service contract with Ms. Patongtarn Shinawatra with the characteristics of conditions and discounts for the group of persons under the contract with a discount rate of 15% (which is a discount rate with exclusion conditions such as doctor's fees, dental fees, physical therapy fees, doctor's reading fees, medical technical diagnostic examination and pathology (special), beauty fees, and lump-sum payment service fees) and payment terms of 30 days from the date of billing, which are in accordance with the discount criteria under the medical service contract set out in the Company's pricing policy. At the time of the preparation of the aforementioned medical service contract. · Description: The Company provides medical services to a group of individuals under a medical service contract. between the Company and Mr. Bannapot Damapong (the contract covers Mr. Bannapot Damapong and persons under contract) The program in which Mr. Bannapot Damapong paid the medical expenses to the company on behalf of the service recipients. · As of yesteryear: 0.09 · Nature of transaction: Outstanding trade receivables at the end of the period · Audit committee opinion: The Audit Committee has considered that the transaction is beneficial to the Company. In order to expand the customer base that comes to use the Company's services, the price, conditions, and services, as well as discounts under the medical service contract of Mr. Bannapot Damapong, are within the normal criteria of customers under the medical service contract and customers according to the Company's price policy guidelines. · As of year before yesteryear: 0.07
32.28 · Necessity: Doctors who hold the position of directors or executives are examined and treated at the hospital by The remuneration is comparable to the rate of medical fees paid by the Company to other doctors who are similarly qualified to doctors who hold the position of director and/or The hospital focuses on the quality of medical services as well as expertise in providing medical services for complex diseases, so it is necessary to determine appropriate remuneration and create motivation. It can attract quality doctors to hospitals and reduce the risk of shortage of medical personnel. · Description: The Company pays compensation in the form of doctor's fees to doctors who have been examined in the hospital. Under the Memorandum of Agreement on the Use of the Clinic for Dental Practice, 11 people · As of yesteryear: 34.37 · Nature of transaction: Doctor's Fee Cost · Audit committee opinion: The Company is required to pay the remuneration of such doctors at the same rate as other doctors with similar qualifications to the doctors in the position. · As of year before yesteryear: 32.33 · 4.09 · Necessity: Doctors who hold the position of directors or executives are examined and treated at the hospital by The remuneration is comparable to the rate of medical fees paid by the Company to other doctors who are similarly qualified to doctors who hold the position of director and/or The hospital focuses on the quality of medical services as well as expertise in providing medical services for complex diseases, so it is necessary to determine appropriate remuneration and create motivation. It can attract quality doctors to hospitals and reduce the risk of shortage of medical personnel. · Description: The Company pays compensation in the form of doctor's fees to doctors who have been examined in the hospital. Under the Memorandum of Agreement on the Use of the Clinic for Dental Practice, 11 people · As of yesteryear: 3.63 · Nature of transaction: The amount of outstanding medical fees at the end of the period · Audit committee opinion: The Company is required to pay the remuneration of such doctors at the same rate as other doctors with similar qualifications to the doctors in the position. · As of year before yesteryear: 4.64
0.36 · Necessity: The Company has appointed a qualified person with medical knowledge and expertise who has served as the Chief Medical Officer of the Company as a consultant, who is not a full-time employee, to provide advice. Consulting and participating in quality development activities and academic training meetings of the Company. · Description: The Company pays monthly remuneration to the Company's external consultants. · As of yesteryear: 0.44 · Nature of transaction: Consultant Fee · Audit committee opinion: The Company is required to pay such remuneration as remuneration for consultants in the performance of their duties, and such remuneration is at a rate comparable to that of consultants other than persons who may have conflicts with the Company with the same scope of consultation. · As of year before yesteryear: 0.6

Policy & Future Trends

Policy, Measures & Approval Process

However, In the past year, the Company has not conducted any connected transactions that require approval from the Board of Directors or shareholders in accordance with the requirements of the Stock Exchange of Thailand, and has not violated or complied with the rules on disclosure of related party transactions and asset trading.


Policies and Trends for Future Transactions

Possible inter-items in the future The Board of Directors shall comply with the Securities and Exchange Act and the regulations, announcements, orders or requirements of the Capital Market Supervisory Board. The Securities and Exchange Commission and the Stock Exchange of Thailand However, The Company will disclose the related party transactions in the Annual Registration Statement and the notes to the financial statements audited by the Company's auditors, as well as comply with the requirements regarding the disclosure of the Company's related party transactions in accordance with the Financial Reporting Standards issued under the Accounting Profession Act, B.E. 2547 Including amendments

The Company may continue to enter into transactions in the future by determining the prices and trading conditions in accordance with the normal course of business, as well as those assigned to persons and/or companies that are not in conflict or related to each other, such as providing medical services to the contracting companies. Payment of remuneration in the form of medical fees Welfare for medical expenses, etc. The upcoming related party transactions are in accordance with the Company's normal business operations and are primarily for the benefit of the Company and its shareholders.

The Company's inter-party transactions that occur and may occur in the future shall be necessary and/or reasonable for the best interests of the Company and shall be in accordance with the nature of general business operations, and such transactions, prices and conditions of the transactions shall be fair and in accordance with the normal business (Fair and at arm’s length basisThere is no transfer of interest between the Company and persons who may have conflicts, and the Audit Committee of the Company will give an opinion on the necessity and appropriateness of the transaction. In addition, if there is a transaction between the two parties. referee Executives or persons who may have conflicts or interests will not be able to participate or have the right to vote in considering and approving the transaction. In order to ensure transparency and independence in considering and making real transactions, and when considering the structure of the company, it can be seen that the company does not have a business group structure, so there are no transactions between each other, which will cause a conflict of interest.

In addition, if the company has a large-scale inter-party transaction and must obtain approval from shareholders in accordance with the requirements of the Stock Exchange of Thailand. The Company will fully disclose all details as specified by the Stock Exchange, including the date, month, year of the transaction agreement, the parties involved Nature of Interests General characteristics of the list Asset Details: Appraisal price of an independent appraiser authorized by the Securities and Exchange Commission Settlement Criteria used to determine the total value of an item Reason for the transaction (benefits/advantages of the transaction) Size of transaction Independent Financial Advisor's Opinion Directors who do not have the right to vote at the Board of Directors meeting, the opinion of the Board of Directors, the opinion of the Audit Committee and/or the Company's directors that differ from the opinion of the Board of Directors List of shareholders with interests who do not have the right to vote and other information that may have a significant impact on shareholders' decision-making.


Policies or trends in future transactions and compliance with the obligations given by the Company in the prospectus.

Measures and procedures for approving the inter-party transaction

Pursuant to the Board of Directors' Resolution No. 3/2018 on 12 March 2018, the Company's inter-party transaction policy and principles regarding commercial agreements with general trade terms were approved. In transactions between the Company and the directors. The Company will comply with the Securities and Exchange Act and the regulations, announcements, orders or requirements of the Capital Market Supervisory Board. The Securities and Exchange Commission and the Stock Exchange of Thailand However, referee Executives or persons who may have conflicts or interests will not be able to participate or have the right to vote in considering and approving the transaction. However, Entering into a Transaction The company adheres to the principle of as follows

- It is a transaction that has gone through a transparent approval process by the directors. and/or executives (as the case may be) with responsibility, prudence and honesty. Stakeholders are not involved in decision-making.

- It is a transaction that is made with the interests of the company in mind as if it were a transaction with a third party.

- There is a tracking and monitoring system that ensures that transactions are carried out in accordance with the correct procedures.

Measures and procedures for inter-party transactions

The Company has established measures and procedures for inter-party transactions. as follows:

(1) Consideration of the Transaction The Company will use the same criteria as general customers and/or individuals, as well as in accordance with the Company's normal operating procedures, to support business operations, which must be fair and reasonable and bring maximum benefits to the Company.

(2) In case there is no such price. The Company will consider comparing the price of the goods or services with the external price. Under the same or similar conditions.

(3) The Company may make use of the reports of independent appraisers appointed by the Company to compare prices for significant related party transactions to ensure that such prices are reasonable and in the best interests of the Company.

(4) Transactions of the Company's Directors. Executives or persons who may have conflicts or related interests that are not normal business transactions or have different commercial conditions from transactions with general customers or third parties may proceed only with the approval of the Board of Directors by a majority vote. There must be no directors. Executives or persons who may have conflicts or related interests shall participate in the consideration and approval of the transaction and must not have any special conditions or requirements that deviate from the usual criteria set by the Company.

(5) If the Company has other related transactions that meet the requirements of the Stock Exchange of Thailand. Such requirements must be strictly observed.

(6) The Company must disclose information on transactions that may have a conflict of interest or a transaction between parties in accordance with the rules set by the Office of the Securities and Exchange Commission. The Stock Exchange of Thailand and/or related agencies shall be determined and in accordance with accounting standards and disclosed in the Annual Registration Statement. Annual report or any other report form as the case may be.

(7) The Internal Audit Division shall review the transactions in accordance with the audit plan, which must report to the Audit Committee and have measures to control, audit, and supervise the random review of actual transactions in accordance with the contract or policies or conditions stipulated.

Approval of Connected Transactions or Connected Transactions

In the event that the law requires the approval of the Board of Directors or the shareholders' meeting prior to entering into the related party transaction (if any), the Company will arrange for the Audit Committee to attend the meeting to consider and give opinions on the necessity of the transaction and the reasonableness of the transaction. In entering into a normal business transaction or a normal business support transaction which is a commercial agreement with general commercial conditions and a transaction that is a commercial agreement that is not a general commercial condition, the following principles shall be followed:

(1) Transactions that are commercial agreements with general terms of trade.

A transaction that is a normal business transaction or a normal business support transaction with a commercial agreement with general commercial conditions and is beneficial to the Company's business or operations. The management or the Board of Directors proposes that the Board of Directors approve the transaction agreement in principle before entering into such a transaction. If the transaction contains a commercial agreement in the same manner as a person would do with a general party in the same situation, with commercial bargaining power without influence in his or her status as a director. Executives or related persons. The management will prepare a summary report of the transaction. To report to the Audit Committee and the Board of Directors meetings every quarter.

However, Transactions that comply with general trade conditions are trade conditions with fair prices and conditions and do not cause transfer of benefits.

- It is the price and conditions received by the Company or to the public.

- It is the price and conditions that the connected person gives to the general public.

- It is the price and condition under which the Company can show that the business operator is in a similar manner to the public.

(2) Transactions that are commercial agreements that are not generally trade terms.

The transaction is a non-conditional commercial agreement in general, and the Audit Committee shall consider and give an opinion on the necessity and reasonableness of the transaction before presenting it to the Board of Directors and/or the shareholders' meeting (as the case may be) for approval. and the Office of the Securities and Exchange Commission, including compliance with the requirements regarding the disclosure of information on connected or connected transactions. The Company will disclose such related transactions in the notes to the Company's financial statements that have been audited or reviewed by the Company's auditors.

In the event that the Audit Committee does not have the expertise to consider the inter-party transactions that may occur. The Company will appoint persons with special knowledge, expertise or expertise, such as auditors, appraisers, or experts in related fields, who are independent of the Company, and persons who may have conflicts with the Company, to provide opinions on such transactions for the purpose of making decisions of the Audit Committee and/or the Board of Directors and/or the Shareholders' Meeting (as the case may be) to ensure that such transactions are necessary and reasonable taking into account the interests of the Company and shareholders.

Policies and Trends in Future Transactions

Transactions that may occur in the future. The Board of Directors shall comply with the Securities and Exchange Act and the regulations, announcements, orders or requirements of the Capital Market Supervisory Board. The Securities and Exchange Commission and the Stock Exchange of Thailand However, The Company discloses the related party transactions in the annual registration statement and notes to the financial statements audited by the Company's auditors, as well as complies with the requirements regarding the disclosure of the Company's related party transactions in accordance with the Financial Reporting Standards issued under the Accounting Profession Act, B.E. 2547 (2004), as amended.

The Company may continue to enter into cross-party transactions in the future. By setting the same prices and normal trading conditions of the business as those assigned to individuals and/or companies that are not in conflict or related, such as providing medical services to the contracting companies. Remuneration in the form of medical fees, etc. The upcoming related party transactions are in accordance with the Company's normal business operations and are primarily for the benefit of the Company and its shareholders.

However, The Company's inter-party transactions that occur and may occur in the future shall be necessary and/or reasonable for the best interests of the Company and shall be subject to the nature of general business operations and the transaction prices and conditions of the transaction which are fair and in accordance with the normal business (Fair and at arm’s length basis There is no transfer of interest between the Company and persons who may have conflicts, and the Audit Committee of the Company will give an opinion on the necessity and appropriateness of the transaction. In addition, if there is a transaction between the two parties. referee Executives or persons who may have conflicts or interests will not be able to participate or have the right to vote in considering and approving the transaction.

Contents